The ISO 13485:2003 certification covers the design, development, production, sales and service of the nCounter® Analysis System, NanoString’s multiplexed molecular detection instrument and reagents. The certificate demonstrates that NanoString has successfully implemented a quality management system that conforms to the worldwide standard for medical device and diagnostic manufacturing.
“This achievement demonstrates NanoString’s continued commitment to the highest level of quality management and design controls to ensure delivery of safe and effective products,” said Mary Tedd Allen, Vice President of Manufacturing for NanoString. “Our international customer base can be assured that the products we deliver today are of the highest standards, and that the ISO 13485:2003 criteria will provide a quality foundation upon which we and our partners will develop new diagnostic products.”
The ISO (International Organization for Standardization) is the world's largest developer and publisher of International Standards. NanoString’s ISO 13485:2003 certificate was awarded by LNE / GMED through its subsidiary GMED North America, Inc.
About NanoString Technologies
NanoString Technologies is a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules. Due to its multiplexing ability and ease of use, NanoString’s solution enables researchers to embark on studies that were previously inconceivable. The company’s digital target profiling technology enables a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. NanoString is also developing the technology for use in molecular diagnostics. For more information please visit: www.nanostring.com.
Contact:
For NanoString Technologies, Inc. Nicole Litchfield, 415-793-6468 Nicole@bioscribe.com
